Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ISRCTN42997318) titled 'Study to evaluate the safety, absorption and elimination in the urine of a new diclofenac-based drug administered directly into the bladder' on Jan. 21.
Study Type: Interventional
Study Design:
Allocation: Randomized controlled trial
Masking: Blinded (masking used)
Control: Placebo
Assignment: Single
Purpose: Basic science, Prevention, Treatment
Primary Sponsor: IBSA Institut Biochimique (Switzerland)
Condition:
Urinary tract infections (UTIs)
Urological and Genital Diseases
Intervention:
The study is divided into two parts:
Part A: Healthy volunteers will receive a single dose of the investigational drug (a...